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35. Moody A. Perspective: the big picture. Nature. 2013;502:S95.MMENTARYBicuspid aortopathy and the development of individualized resection
strategiesPaul W. M. Fedak, MD, PhD, FRCSC,a,b and Subodh Verma, MD, PhD, FRCSCc,dIn an effort to better understand current surgical approaches,
we compared the knowledge and attitudes of individual sur-
geons toward the diagnosis and management of bicuspid
aortopathy.1 Surprisingly, surgeons’ approaches often went
outside established guidelines, with marked differences inthe timing, extent, and type of operative strategy of aortic
resection. Bicuspid aortopathy is a commonly encountered
clinical scenario, so why are surgeons so disparate and non-
compliant with current recommendations? We believe that
the heterogeneous nature of the disease and its diverse clin-
ical phenotypes2 may influence a surgeon’s threshold for
aortic replacement, despite current guidelines. Unfortu-
nately, there are no consensus recommendations on the
type or extent of aortic repair for an individual patient
with bicuspid aortopathy, and no randomized clinical trials
are available to better inform clinicians as to whether an
aggressive versus conservative approach is appropriate.
Although arm-deep in a patient’s chest and inspired by the
best intentions, surgeons might avoid the recommendations
in selected patients and recognize that contemporary guide-
lines for aortic resection in patients with bicuspid aortic
valve based solely on maximal aortic diameter are deficient
and lack an appreciation for the numerous factors that may
underlie disease progression.
To achieve optimal clinical outcomes for bicuspid
aortopathy, individualized surgical approaches for patients
with bicuspid aortic valve disease may be a necessity. In
their report in this issue of the Journal, Sievers andgery c November 2014
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Dcolleagues3 examine the outcomes with use of their
preferred approach to manage the ascending aorta during
bicuspid valve surgery. The approach is novel and provides
individualized resection strategies and includes ‘‘in the
moment’’ assessments going far beyond maximal aortic
diameter. It is not surprising that this group of expert
surgeons observed excellent clinical results. The approach
acknowledges and then attempts to balance the surgical
risk with the perceived extent and magnitude of the
aortopathy for each individual patient and then tailors the
type and extent of aortic resection accordingly. The strategy
is unique such that patients at intermediate risk were treated
with aortoplasty compared with complete resection.
Aortoplasty does address the issue of maximal aortic
diameter, but without resection it may also retain affected
aortic tissues at risk of future expansion, rupture, or
dissection. Although the clinical outcomes were adequate,
these patients may not have needed any aortic intervention.
Determination of intermediate risk may not be simple using
current criteria. The lack of randomization or a comparative
group with appropriate analysis is lacking. Surgeons would
not be wrong to adopt the proposed approach. But would
they be right? We simply do not know. Further study with
longer follow-up periods, serial imaging of the aortoplasty
patients, and additional comparative analysis will be needed
to determine whether this approach is indeed preferred and
can be widely recommended.
To optimally address each patient with bicuspid
aortopathy on an individual basis with a tailored surgical
strategy, the science must first advance. We must develop
and validate the predictive tools needed to appropriately
risk stratify patients, and only then can the optimal
treatment strategy be used.4 In this study, intraoperative
criteria were used to estimate the degree of aortopathy
and then guide the surgeon to the extent and best approach
to aortic resection. Sadly, the ‘‘look and feel’’ of the aorta
are subjective criteria that are nonvalidated and likely suffer
from problems of poor sensitivity and specificity. Many sur-
geons use wall thinning and friability in decision-making,
and certainly this is reasonable in the absence of better
alternatives. We believe that the use of advanced imagingThe Journal of Thoracic and Carmodalities in combination with biomarkers may prove to
be superior. By using 4-dimensional flow magnetic
resonance imaging technology, we recently showed that
valve fusion patterns predicted the degree and location of
aortic dilatation.5 Imaging of regional flow abnormalities
may help identify areas at risk of long-term complications
that should be resected. Biomarkers are being explored
and may help identify individual patients with aggressive
phenotypes that may benefit from more extensive and
perhaps earlier resections.6 In combination with advanced
imaging, these predictive tools could be used to enhance
decision making preoperatively and avoid crucial decisions
‘‘in the moment.’’
To develop individualized resection strategies, we must
advance the science of bicuspid aortic valve aortopathy and
determine the keymolecular and cellular mechanisms under-
lying its progression.7 Until such time, expert surgeons will
continue to use their own individualized approaches for
each patient. The results of this study provide reassurance
that even without the science needed to develop and validate
best practices, surgeons using individualized aortic resection
strategies can and do provide substantial benefits for their pa-
tients with bicuspid aortic valves.References
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